Role of vitamin d receptor activators in cardio-renal syndromes

Area of Science:

• Nephrology
• Cardiology
• Endocrinology

Background:

• Vitamin D deficiency is increasingly recognized for its role in cardiovascular morbidity and mortality.
• In chronic kidney disease (CKD), vitamin D levels decline due to renal impairment, exacerbating cardiovascular risks.
• CKD is associated with secondary hyperparathyroidism, hypocalcemia, hyperphosphatemia, and accelerated vascular calcification, contributing to left ventricular changes.

Purpose of the Study:

• To explore the association between vitamin D deficiency and cardiovascular outcomes in CKD patients.
• To investigate the impact of vitamin D administration on cardio-renal syndrome.
• To assess the potential of vitamin D in preventing cardiovascular and renal complications in CKD.

Main Methods:

• Review of recent studies and clinical data on vitamin D levels in CKD patients.
• Analysis of the effects of vitamin D supplementation on cardiovascular parameters and renal function.
• Evaluation of the role of vitamin D in managing secondary hyperparathyroidism and vascular calcification.

Main Results:

• Vitamin D deficiency is strongly associated with increased cardiovascular morbidity and mortality in CKD.
• Vitamin D administration shows potential cardioprotective and renoprotective effects.
• Supplementation may improve peripheral vascular disease, reduce vascular calcification, enhance cardiac outcomes, and aid blood pressure control.

Conclusions:

• Vitamin D deficiency significantly contributes to cardiovascular complications in chronic kidney disease.
• Vitamin D supplementation demonstrates promising benefits for cardiovascular and renal health in CKD.
• Vitamin D therapy may be crucial for preventing cardio-renal syndrome and its associated adverse outcomes.